Iannone Robert (CIK 1737329) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell JAZZ (3,764 shares), Sell JAZZ (6,209 shares), Buy JAZZ (14,822 shares), Buy JAZZ (11,699 shares), Sell JAZZ (4,140 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 3,764 | $894,778 |
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 6,209 | $1.2M |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 14,822 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 11,699 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 4,140 | $708,602 |
| 2025-11-19 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 7,159 | $1.2M |
| 2025-03-12 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 2,403 | $332,599 |
| 2025-03-07 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 5,239 | $727,959 |
| 2025-03-07 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 5,532 | $764,578 |
| 2025-03-07 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 1,548 | $216,720 |
| 2025-03-03 | Jazz Pharmaceuticals plc (JAZZ) | EVP, G R&D and CMO | Buy | 17,718 | $0 |
| 2025-03-03 | Jazz Pharmaceuticals plc (JAZZ) | EVP, G R&D and CMO | Buy | 8,859 | $0 |
| 2025-01-22 | Jazz Pharmaceuticals plc (JAZZ) | EVP, G R&D and CMO | Buy | 7,506 | $0 |
| 2025-01-22 | Jazz Pharmaceuticals plc (JAZZ) | EVP, G R&D and CMO | Sell | 2,181 | $267,434 |
Source: SEC Form 4 filings · as of 2026-07-02